Fred Alger Management, LLC Bio N Tech Se Transaction History
Fred Alger Management, LLC
- $20.2 Billion
- Q2 2025
A detailed history of Fred Alger Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Fred Alger Management, LLC holds 13,839 shares of BNTX stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,839
Previous 61,930
77.65%
Holding current value
$1.44 Million
Previous $5.64 Million
73.88%
% of portfolio
0.01%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding BNTX
# of Institutions
320Shares Held
40.7MCall Options Held
1.39MPut Options Held
1.52M-
Baillie Gifford & CO7.88MShares$819 Million0.61% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$440 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$416 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$374 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$197 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...